Benchmark reaffirmed a buy rating on Ingredion stock.
2 reports, 1 independent
Updated Aug 5
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Benchmark reaffirmed a buy rating on Ingredion stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Benchmark reaffirmed a buy rating on the stock of Alpha Tau Medical.
- Benchmark reissued a buy rating on SFL Corporation Ltd. shares.
- Benchmark and Jefferies reaffirmed buy ratings while the FDA cited toxicity findings for Bright Minds Biosciences Inc.
- Benchmark lifted its price objective and gave a buy rating for Amazon.com.
- MarketBeat reported the stock's average rating as Benchmark and Jefferies reiterated buy ratings for Bright Minds Biosciences Inc.